Oxford Cannabinoid Technologies Holdings PLC on Tuesday announced narrowing losses and a new government tax credit, as shares fell following a fundraise of GBP1.2 million for its latest programme.
Oxford Cannabinoid Technologies Holdings PLC on Tuesday said it has successfully completed the dosing of all the cohorts of its Phase 1 study for its lead pharmaceutical asset, OCT461201.
The.
Oxford Cannabinoid Technologies Holdings PLC said on Monday that it was formally expanding its research & development strategy into oncology, having discovered a potential cannabinoid-based treatment.
IN BRIEF: Oxford Cannabinoid submits trials application for agonist lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.